Vapaliximab Biosimilar - Research Grade

Human

AOC3ï؟½

5mg/ml

IgG2 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Q16853

Blue ice

AOC3 (VAP-1) is an endothelial amine oxidase and adhesion molecule that regulates leukocyte recruitment during inflammation, a topic of sustained interest in vascular biology research. Provided as an unconjugated, non-therapeutic analog of vapaliximab, this recombinant human IgG2 antibody targets AOC3 and is supplied for research use only (RUO). It is formulated to a low-endotoxin specification suitable for in vivo use and produced in scalable milligram-to-gram quantities to support heavy-usage and high-throughput laboratories. Applications include adhesion and enzyme-activity assays, in vitro inflammation screening, control work, and preclinical models of leukocyte trafficking.

Amine oxidase [copper-containing] 3, Vacular adhesion Protein 1, VAP1

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks